At the recently concluded 2nd ATTD-ASIA Conference, Teljane Medical made a strong and impactful appearance as an exhibitor, showcasing multiple innovative technologies that highlight new possibilities in glucose management.
The booth attracted continuous attention from clinical experts, researchers, and industry partners worldwide, with the product feature of “15-minute activation and up to 21 days of wear” emerging as a key highlight throughout discussions. Distributors from various countries and regions visited the booth, expressed strong interest in Instara™-1, and engaged in in-depth conversations with the team to explore potential collaborations.
We look forward to reconnecting at ATTD 2026 in Barcelona, as we continue to advance the future of chronic disease management together.
